Jeanette Lundin

1PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 18, 2022
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.

Jeanette Lundin, Tom A Mulder, Magdalena Kättström

Pageof 1

Frequent Collaborators

1 joint publications

Tom A Mulder

1 joint publications

Tove Wästerlid

1 joint publications

Lotta Hansson

1 joint publications

Marzia Palma